Skip to main content

Over two million people in England may be eligible for surgery to treat obesity

Over two million people in England may be eligible for surgery to treat obesity, according to new research published in JRSM Open. However, fewer than 7000 patients underwent these procedures in 2011.

Carrying out more bariatric surgery procedures would help to reduce obesity-related ill health, the study authors from Imperial College London said, but the NHS may need to invest in more resources to meet demand.

Bariatric surgery – a set of surgical procedures performed on obese people to decrease their stomach size – can greatly reduce the likelihood of death from obesity-related diseases such as type 2 diabetes, stroke or coronary heart disease.

Despite clear guidelines outlining who can undergo such surgery with the NHS, and evidence that these procedures are cost-effective in the long run, less than one per cent of those eligible have weight loss surgery each year. The researchers say this raises questions about why more procedures are not currently being carried out.

One possible reason is lack of awareness of the surgical procedures and potential benefits. Commitment to lifestyle intervention is also an important barrier, as patients must be willing to enter a full life-changing programme involving intensive management in a specialist obesity service and commitment to long-term follow-up.

Those eligible are more likely to be women, be retired, have no formal education and be from a lower socio-economic status than the general population.

Dr Sonia Saxena, from the Department of Primary Care and Public Health at Imperial College London, said: “Performing more operations could be very good for the population in terms of improving patient health. You could cut down on a number of very severe conditions and extend life expectancy in patients who are likely to suffer significant problems as a result of their obesity.”

But the research, funded by the Higher Education Funding Council for England and the National Institute for Health Research, revealed that the capacity of health services to meet this demand is limited.

The NHS would be overwhelmed because there isn’t the resource to actually carry out this number of operations,” Dr Saxena added.

If everyone who was eligible came forward there would most likely be a restriction because of funding and resource allocation at the local level.”

To calculate the number of eligible people, twe used population data from the 2006 Health Survey for England, a nationally representative household survey carried out every year by the government to plan health services and make policy decisions.

We combined them with guidelines from the 2006 UK National Institute for Health and Clinical Excellence (NICE). The NICE guidelines assess eligibility for bariatric surgery according to a person’s body mass index (BMI), a measure of body shape based on mass and height. People with a BMI exceeding 40, or those with a BMI between 35 and 40 and suffering from one or more obesity-related diseases, are eligible for bariatric surgery with the NHS.

But Dr Saxena explained that eligibility based on NICE guidelines alone is not the end of the story. “We know from our previous work in the United States that fewer bariatric surgery operations are carried out in disadvantaged groups who are most in need of the operation because of a lack of health coverage. But everyone who is eligible is entitled to the operation in the NHS and there is a huge potential health gain. Some of those who are eligible may not be aware they could benefit or willing to make the lifestyle changes for a successful procedure.”

Reference: A. Ahmad et al. 'Eligibility for bariatric surgery among adults in England: analysis of a national cross-sectional survey.' JRSM Open January 2014 vol. 5 no. 1

Media Coverage
Daily Mirror
Daily Express
Daily Mail


Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.